TreeWAS – Variant ID: rs12032643

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E05.9 Thyrotoxicosis, unspecified	0.009	0.991	0.000
L98.8 Other specified disorders of skin and subcutaneous tissue	0.007	0.993	0.000
D22.5 Melanocytic naevi of trunk	0.007	0.993	0.000
J33.9 Nasal polyp, unspecified	0.007	0.993	0.000
M54.46 Lumbago with sciatica (Lumbar region)	0.000	0.993	0.007
J33.8 Other polyp of sinus	0.007	0.993	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.007	0.993	0.000
J33 Nasal polyp	0.006	0.994	0.000
M54.4 Lumbago with sciatica	0.000	0.994	0.006
L89.1 Stage II decubitus ulcer	0.006	0.994	0.000
J33.0 Polyp of nasal cavity	0.006	0.994	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.006	0.994	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.006	0.994	0.000
E10.4 With neurological complications	0.006	0.994	0.000
M54.49 Lumbago with sciatica (Site unspecified)	0.000	0.995	0.005
G81.9 Hemiplegia, unspecified	0.000	0.995	0.005
E55.9 Vitamin D deficiency, unspecified	0.005	0.995	0.000
M54.57 Low back pain (Lumbosacral region)	0.000	0.995	0.005
E11.4 With neurological complications	0.005	0.995	0.000
N64.5 Other signs and symptoms in breast	0.005	0.995	0.000
S62.30 Fracture of other metacarpal bone (closed)	0.005	0.995	0.000
M54.47 Lumbago with sciatica (Lumbosacral region)	0.000	0.995	0.005
E05.8 Other thyrotoxicosis	0.005	0.995	0.000
E05.5 Thyroid crisis or storm	0.005	0.995	0.000
E05.4 Thyrotoxicosis factitia	0.005	0.995	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.005	0.995	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.005	0.995	0.000
J33.1 Polypoid sinus degeneration	0.005	0.995	0.000
K12.1 Other forms of stomatitis	0.000	0.995	0.005
M54.58 Low back pain (Sacral and sacrococcygeal region)	0.000	0.995	0.005
M54.48 Lumbago with sciatica (Sacral and sacrococcygeal region)	0.000	0.995	0.005
M54.45 Lumbago with sciatica (Thoracolumbar region)	0.000	0.995	0.005
M54.44 Lumbago with sciatica-Thoracic	0.000	0.995	0.005
M54.43 Lumbago with sciatica-Cervicothoracic	0.000	0.995	0.005
M54.42 Lumbago with sciatica-Cervical	0.000	0.995	0.005
M54.41 Lumbago with sciatica-Occipit-atl-axl	0.000	0.995	0.005
M54.40 Lumbago with sciatica (Multiple sites in spine)	0.000	0.995	0.005
M54.5 Low back pain	0.000	0.995	0.005
M54.9 Dorsalgia, unspecified	0.000	0.995	0.005
E10.2 With renal complications	0.005	0.995	0.000
E10 Insulin-dependent diabetes mellitus	0.005	0.995	0.000
E10.1 With ketoacidosis	0.004	0.996	0.000
M54 Dorsalgia	0.000	0.996	0.004
M54.90 Dorsalgia, unspecified (Multiple sites in spine)	0.000	0.996	0.004
E55 Vitamin D deficiency	0.004	0.996	0.000
M54.99 Dorsalgia, unspecified (Site unspecified)	0.000	0.996	0.004
R10.3 Pain localised to other parts of lower abdomen	0.004	0.996	0.000
M54.55 Low back pain (Thoracolumbar region)	0.000	0.996	0.004
M54.97 Dorsalgia, unspecified (Lumbosacral region)	0.000	0.996	0.004
G63.2 Diabetic polyneuropathy	0.004	0.996	0.000
M54.3 Sciatica	0.000	0.996	0.004
E11 Non-insulin-dependent diabetes mellitus	0.004	0.996	0.000
M54.50 Low back pain (Multiple sites in spine)	0.000	0.996	0.004
M54.94 Dorsalgia, unspecified (Thoracic region)	0.000	0.996	0.004
D23.6 Skin of upper limb, including shoulder	0.004	0.996	0.000
M54.96 Dorsalgia, unspecified (Lumbar region)	0.000	0.996	0.004
M54.54 Low back pain-Thoracic	0.000	0.996	0.003
M54.53 Low back pain-Cervicothoracic	0.000	0.996	0.003
M54.52 Low back pain-Cervical	0.000	0.996	0.003
M54.51 Low back pain-Occipit-atl-axl	0.000	0.996	0.003
M11.26 Other chondrocalcinosis (Lower leg)	0.000	0.996	0.004
M54.98 Dorsalgia, unspecified (Sacral and sacrococcygeal region)	0.000	0.996	0.003
M54.95 Dorsalgia, unspecified (Thoracolumbar region)	0.000	0.996	0.003
M54.93 Dorsalgia, unspecified (Cervicothoracic region)	0.000	0.996	0.003
M54.91 Dorsalgia, unspecified (Occipito-atlanto-axial region)	0.000	0.996	0.003
E10.7 With multiple complications	0.003	0.996	0.000
E10.6 With other specified complications	0.003	0.996	0.000
E10.0 With coma	0.003	0.996	0.000
I46.0 Cardiac arrest with successful resuscitation	0.004	0.996	0.000
M54.8 Other dorsalgia	0.000	0.997	0.003
M54.0 Panniculitis affecting regions of neck and back	0.000	0.997	0.003
N75.1 Abscess of Bartholin's gland	0.003	0.997	0.000
E11.1 With ketoacidosis	0.003	0.997	0.000
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified	0.003	0.997	0.000
M54.92 Dorsalgia, unspecified (Cervical region)	0.000	0.997	0.003
E11.2 With renal complications	0.003	0.997	0.000
M54.36 Sciatica (Lumbar region)	0.000	0.997	0.003
E10.8 With unspecified complications	0.003	0.997	0.000
E10.3 With ophthalmic complications	0.003	0.997	0.000
E10-E14 Diabetes mellitus	0.003	0.997	0.000
L98.0 Pyogenic granuloma	0.003	0.997	0.000
E55.0 Rickets, active	0.003	0.997	0.000
F41.0 Panic disorder [episodic paroxysmal anxiety]	0.003	0.997	0.000
E11.5 With peripheral circulatory complications	0.003	0.997	0.000
G12.2 Motor neuron disease	0.003	0.997	0.000
M54.6 Pain in thoracic spine	0.000	0.997	0.003
G81 Hemiplegia	0.000	0.997	0.003
E50-E64 Other nutritional deficiencies	0.003	0.997	0.000
N64 Other disorders of breast	0.003	0.997	0.000
E10.5 With peripheral circulatory complications	0.003	0.997	0.000
M95.0 Acquired deformity of nose	0.003	0.997	0.000
E11.0 With coma	0.003	0.997	0.000
M54.37 Sciatica (Lumbosacral region)	0.000	0.997	0.003
M54.38 Sciatica (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M54.35 Sciatica (Thoracolumbar region)	0.000	0.997	0.003
M54.34 Sciatica-Thoracic	0.000	0.997	0.003
M54.33 Sciatica-Cervicothoracic	0.000	0.997	0.003
M54.32 Sciatica-Cervical	0.000	0.997	0.003
M54.31 Sciatica-Occipit-atl-axl	0.000	0.997	0.003
M54.30 Sciatica (Multiple sites in spine)	0.000	0.997	0.003
E11.7 With multiple complications	0.003	0.997	0.000
D36.7 Other specified sites	0.003	0.997	0.000
N64.9 Disorder of breast, unspecified	0.003	0.997	0.000
L98.5 Mucinosis of skin	0.003	0.997	0.000
S62.3 Fracture of other metacarpal bone	0.003	0.997	0.000
C84.5 Other and unspecified T-cell lymphomas	0.003	0.997	0.000
E61 Deficiency of other nutrient elements	0.003	0.997	0.000
E11.8 With unspecified complications	0.003	0.997	0.000
L89 Decubitus ulcer	0.003	0.997	0.000
M54.09 Panniculitis affecting regions of neck and back (Site unspecified)	0.000	0.997	0.003
M54.08 Panniculitis affecting regions of neck and back (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M54.07 Panniculitis affecting regions of neck and back (Lumbosacral region)	0.000	0.997	0.003
M54.06 Panniculitis affecting regions of neck and back (Lumbar region)	0.000	0.997	0.003
M54.05 Panniculitis affecting regions of neck and back (Thoracolumbar region)	0.000	0.997	0.003
M54.04 Panniculitis affecting regions of neck and back (Thoracic region)	0.000	0.997	0.003
M54.03 Panniculitis affecting regions of neck and back (Cervicothoracic region)	0.000	0.997	0.003
M54.02 Panniculitis affecting regions of neck and back (Cervical region)	0.000	0.997	0.003
M54.01 Panniculitis affecting regions of neck and back (Occipito-atlanto-axial region)	0.000	0.997	0.003
M54.00 Panniculitis affecting regions of neck and back (Multiple sites in spine)	0.000	0.997	0.003
M54.89 Other dorsalgia (Site unspecified)	0.000	0.997	0.003
M54.88 Other dorsalgia (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M54.87 Other dorsalgia (Lumbosacral region)	0.000	0.997	0.003
M54.86 Other dorsalgia (Lumbar region)	0.000	0.997	0.003
M54.85 Other dorsalgia (Thoracolumbar region)	0.000	0.997	0.003
M54.84 Other dorsalgia (Thoracic region)	0.000	0.997	0.003
M54.83 Other dorsalgia (Cervicothoracic region)	0.000	0.997	0.003
M54.82 Other dorsalgia (Cervical region)	0.000	0.997	0.003
M54.81 Other dorsalgia (Occipito-atlanto-axial region)	0.000	0.997	0.003
M54.80 Other dorsalgia (Multiple sites in spine)	0.000	0.997	0.003
C84 Peripheral and cutaneous T-cell lymphomas	0.003	0.997	0.000
N64.4 Mastodynia	0.003	0.997	0.000
E61.2 Magnesium deficiency	0.003	0.997	0.000
L98.7 Excessive and redundant skin and subcutaneous tissue	0.003	0.997	0.000
L98.6 Other infiltrative disorders of skin and subcutaneous tissue	0.003	0.997	0.000
L98.3 Eosinophilic cellulitis [Wells]	0.003	0.997	0.000
L98.2 Febrile neutrophilic dermatosis [Sweet]	0.003	0.997	0.000
L98.1 Factitial dermatitis	0.003	0.997	0.000
K75.8 Other specified inflammatory liver diseases	0.003	0.997	0.000
C83.3 Large cell (diffuse)	0.003	0.997	0.000
E11.6 With other specified complications	0.003	0.997	0.000
E12 Malnutrition-related diabetes mellitus	0.003	0.997	0.000
M54.39 Sciatica (Site unspecified)	0.000	0.997	0.003
F41.1 Generalised anxiety disorder	0.003	0.997	0.000
L89.3 Stage IV decubitus ulcer	0.003	0.997	0.000
L89.2 Stage III decubitus ulcer	0.002	0.997	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.002
F43.0 Acute stress reaction	0.002	0.997	0.000
F41 Other anxiety disorders	0.003	0.997	0.000
C84.4 Peripheral T-cell lymphoma	0.002	0.997	0.000
M54.2 Cervicalgia	0.000	0.997	0.002
M54.69 Pain in thoracic spine-Site unspe	0.000	0.997	0.002
M54.68 Pain in thoracic spine-Sacral/sacrococ	0.000	0.997	0.002
M54.67 Pain in thoracic spine-Lumbosacral	0.000	0.997	0.002
M54.66 Pain in thoracic spine-Lumbar	0.000	0.997	0.002
M54.65 Pain in thoracic spine (Thoracolumbar region)	0.000	0.997	0.002
M54.63 Pain in thoracic spine (Cervicothoracic region)	0.000	0.997	0.002
M54.62 Pain in thoracic spine-Cervical	0.000	0.997	0.002
M54.61 Pain in thoracic spine-Occipit-atl-axl	0.000	0.997	0.002
M54.60 Pain in thoracic spine (Multiple sites in spine)	0.000	0.997	0.002
G81.1 Spastic hemiplegia	0.000	0.997	0.002
G81.0 Flaccid hemiplegia	0.000	0.997	0.002
E64 Sequelae of malnutrition and other nutritional deficiencies	0.002	0.998	0.000
E63 Other nutritional deficiencies	0.002	0.998	0.000
E56 Other vitamin deficiencies	0.002	0.998	0.000
E51 Thiamine deficiency	0.002	0.998	0.000
E50 Vitamin A deficiency	0.002	0.998	0.000
E60 Dietary zinc deficiency	0.002	0.998	0.000
E59 Dietary selenium deficiency	0.002	0.998	0.000
E58 Dietary calcium deficiency	0.002	0.998	0.000
E54 Ascorbic acid deficiency	0.002	0.998	0.000
E52 Niacin deficiency [pellagra]	0.002	0.998	0.000
N64.3 Galactorrhoea not associated with childbirth	0.002	0.998	0.000
N64.2 Atrophy of breast	0.002	0.998	0.000
N64.0 Fissure and fistula of nipple	0.002	0.998	0.000
E13 Other specified diabetes mellitus	0.002	0.998	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C84.0 Mycosis fungoides	0.002	0.998	0.000
N64.1 Fat necrosis of breast	0.002	0.998	0.000
M54.1 Radiculopathy	0.000	0.998	0.002
F43 Reaction to severe stress, and adjustment disorders	0.002	0.998	0.000
F41.8 Other specified anxiety disorders	0.002	0.998	0.000
N97.9 Female infertility, unspecified	0.002	0.998	0.000
E00-E07 Disorders of thyroid gland	0.002	0.998	0.000
M54.59 Low back pain (Site unspecified)	0.000	0.998	0.002
S62.31 Fracture of other metacarpal bone (open)	0.002	0.998	0.000
E53 Deficiency of other B group vitamins	0.002	0.998	0.000
C81.0 Lymphocytic predominance	0.002	0.998	0.000
E61.9 Deficiency of nutrient element, unspecified	0.002	0.998	0.000
E61.8 Deficiency of other specified nutrient elements	0.002	0.998	0.000
E61.7 Deficiency of multiple nutrient elements	0.002	0.998	0.000
E61.6 Vanadium deficiency	0.002	0.998	0.000
E61.5 Molybdenum deficiency	0.002	0.998	0.000
E61.4 Chromium deficiency	0.002	0.998	0.000
E61.3 Manganese deficiency	0.002	0.998	0.000
E61.0 Copper deficiency	0.002	0.998	0.000
F43.1 Posttraumatic stress disorder	0.002	0.998	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.002	0.998	0.000
F45.8 Other somatoform disorders	0.002	0.998	0.000
C81 Hodgkin's disease	0.002	0.998	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.002	0.998	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.002	0.998	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.002	0.998	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.002	0.998	0.000
C84.3 Lymphoepithelioid lymphoma	0.002	0.998	0.000
C84.2 T-zone lymphoma	0.002	0.998	0.000
C84.1 Sezary's diease	0.002	0.998	0.000
N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess	0.002	0.998	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.002
E28.2 Polycystic ovarian syndrome	0.002	0.998	0.000
L98.4 Chronic ulcer of skin, not elsewhere classified	0.002	0.998	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.002	0.998	0.000
C95 Leukaemia of unspecified cell type	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
M54.29 Cervicalgia-Site unspe	0.000	0.998	0.002
E11.3 With ophthalmic complications	0.002	0.998	0.000
E61.1 Iron deficiency	0.002	0.998	0.000
I87.8 Other specified disorders of veins	0.002	0.998	0.000
L89.0 Stage I decubitus ulcer and pressure area	0.002	0.998	0.000
C93 Monocytic leukaemia	0.002	0.998	0.000
E12.9 Without complications	0.002	0.998	0.000
E12.8 With unspecified complications	0.002	0.998	0.000
E12.7 With multiple complications	0.002	0.998	0.000
E12.6 With other specified complications	0.002	0.998	0.000
E12.5 With peripheral circulatory complications	0.002	0.998	0.000
E12.4 With neurological complications	0.002	0.998	0.000
E12.3 With ophthalmic complications	0.002	0.998	0.000
E12.2 With renal complications	0.002	0.998	0.000
E12.1 With ketoacidosis	0.002	0.998	0.000
E12.0 With coma	0.002	0.998	0.000
F43.2 Adjustment disorders	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
V23.4 Driver injured in traffic accident	0.002	0.998	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
C88 Malignant immunoproliferative diseases	0.002	0.998	0.000
F45 Somatoform disorders	0.002	0.998	0.000
M11.2 Other chondrocalcinosis	0.000	0.998	0.002
N18.0 End-stage renal disease	0.002	0.998	0.000
O24.4 Diabetes mellitus arising in pregnancy	0.000	0.998	0.002
R59.0 Localised enlarged lymph nodes	0.002	0.998	0.000
C95.0 Acute leukaemia of unspecified cell type	0.002	0.998	0.000
F41.3 Other mixed anxiety disorders	0.002	0.998	0.000
H43.3 Other vitreous opacities	0.002	0.998	0.000
R79.9 Abnormal finding of blood chemistry, unspecified	0.002	0.998	0.000
M54.28 Cervicalgia-Sacral/sacrococ	0.000	0.998	0.002
M54.27 Cervicalgia-Lumbosacral	0.000	0.998	0.002
M54.26 Cervicalgia-Lumbar	0.000	0.998	0.002
M54.25 Cervicalgia-Thoracolumbar	0.000	0.998	0.002
M54.24 Cervicalgia-Thoracic	0.000	0.998	0.002
M54.21 Cervicalgia (Occipito-atlanto-axial region)	0.000	0.998	0.002
M54.20 Cervicalgia-Mult site	0.000	0.998	0.002
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
M54.64 Pain in thoracic spine (Thoracic region)	0.000	0.998	0.002
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
E27.1 Primary adrenocortical insufficiency	0.002	0.998	0.000
M54.18 Radiculopathy (Sacral and sacrococcygeal region)	0.000	0.998	0.002
E50.9 Vitamin A deficiency, unspecified	0.002	0.998	0.000
E50.8 Other manifestations of vitamin A deficiency	0.002	0.998	0.000
E50.7 Other ocular manifestations of vitamin A deficiency	0.002	0.998	0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.002	0.998	0.000
E50.5 Vitamin A deficiency with night blindness	0.002	0.998	0.000
E50.4 Vitamin A deficiency with keratomalacia	0.002	0.998	0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.002	0.998	0.000
E50.2 Vitamin A deficiency with corneal xerosis	0.002	0.998	0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.002	0.998	0.000
E50.0 Vitamin A deficiency with conjunctival xerosis	0.002	0.998	0.000
E51.9 Thiamine deficiency, unspecified	0.002	0.998	0.000
E51.8 Other manifestations of thiamine deficiency	0.002	0.998	0.000
E51.2 Wernicke's encephalopathy	0.002	0.998	0.000
E51.1 Beriberi	0.002	0.998	0.000
E56.9 Vitamin deficiency, unspecified	0.002	0.998	0.000
E56.8 Deficiency of other vitamins	0.002	0.998	0.000
E56.1 Deficiency of vitamin K	0.002	0.998	0.000
E56.0 Deficiency of vitamin E	0.002	0.998	0.000
E63.9 Nutritional deficiency, unspecified	0.002	0.998	0.000
E63.8 Other specified nutritional deficiencies	0.002	0.998	0.000
E63.1 Imbalance of constituents of food intake	0.002	0.998	0.000
E63.0 Essential fatty acid [EFA] deficiency	0.002	0.998	0.000
E64.9 Sequelae of unspecified nutritional deficiency	0.002	0.998	0.000
E64.8 Sequelae of other nutritional deficiencies	0.002	0.998	0.000
E64.3 Sequelae of rickets	0.002	0.998	0.000
E64.2 Sequelae of vitamin C deficiency	0.002	0.998	0.000
E64.1 Sequelae of vitamin A deficiency	0.002	0.998	0.000
E64.0 Sequelae of protein-energy malnutrition	0.002	0.998	0.000
C93.1 Chronic monocytic leukaemia	0.002	0.998	0.000
E13.8 With unspecified complications	0.002	0.998	0.000
E13.7 With multiple complications	0.002	0.998	0.000
E13.6 With other specified complications	0.002	0.998	0.000
E13.5 With peripheral circulatory complications	0.002	0.998	0.000
E13.4 With neurological complications	0.002	0.998	0.000
E13.3 With ophthalmic complications	0.002	0.998	0.000
E13.2 With renal complications	0.002	0.998	0.000
E13.1 With ketoacidosis	0.002	0.998	0.000
E13.0 With coma	0.002	0.998	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C94 Other leukaemias of specified cell type	0.002	0.998	0.000
C92 Myeloid leukaemia	0.002	0.998	0.000
C86 Other specified types of T/NK-cell lymphoma	0.002	0.998	0.000
C81.1 Nodular sclerosis	0.002	0.998	0.000
H43.1 Vitreous haemorrhage	0.002	0.998	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.002	0.998	0.000
M54.15 Radiculopathy (Thoracolumbar region)	0.000	0.998	0.002
M54.14 Radiculopathy (Thoracic region)	0.000	0.998	0.002
M54.13 Radiculopathy (Cervicothoracic region)	0.000	0.998	0.002
M54.11 Radiculopathy (Occipito-atlanto-axial region)	0.000	0.998	0.002
M54.10 Radiculopathy (Multiple sites in spine)	0.000	0.998	0.002
T43.2 Other and unspecified antidepressants	0.000	0.998	0.002
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.998	0.002
F43.8 Other reactions to severe stress	0.002	0.998	0.000
L98.9 Disorder of skin and subcutaneous tissue, unspecified	0.002	0.998	0.000
G63 Polyneuropathy in diseases classified elsewhere	0.002	0.998	0.000
F40-F48 Neurotic, stress-related and somatoform disorders	0.002	0.998	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.002	0.998	0.000
E00 Congenital iodine-deficiency syndrome	0.002	0.998	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
E53.1 Pyridoxine deficiency	0.002	0.998	0.000
E53.0 Riboflavin deficiency	0.002	0.998	0.000
C82.2 Large cell, follicular	0.002	0.998	0.000
C83.7 Burkitt's tumour	0.002	0.998	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
E28 Ovarian dysfunction	0.002	0.998	0.000
M54.16 Radiculopathy (Lumbar region)	0.000	0.998	0.002
C81.7 Other Hodgkin's disease	0.002	0.998	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.002	0.998	0.000
C81.3 Lymphocytic depletion	0.002	0.998	0.000
C81.2 Mixed cellularity	0.002	0.998	0.000
C82.0 Small cleaved cell, follicular	0.002	0.998	0.000
C90.2 Plasmacytoma, extramedullary	0.002	0.998	0.000
I27.9 Pulmonary heart disease, unspecified	0.002	0.998	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
C83.6 Undifferentiated (diffuse)	0.002	0.998	0.000
C83.5 Lymphoblastic (diffuse)	0.002	0.998	0.000
C83.4 Immunoblastic (diffuse)	0.002	0.998	0.000
C83.2 Mixed small and large cell (diffuse)	0.002	0.998	0.000
C83.1 Small cleaved cell (diffuse)	0.002	0.998	0.000
C82.6 Cutaneous follicle centre lymphoma	0.002	0.998	0.000
C82.5 Diffuse follicle centre lymphoma	0.002	0.998	0.000
C82.4 Follicular lymphoma grade IIIb	0.002	0.998	0.000
C82.3 Follicular lymphoma grade IIIa	0.002	0.998	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.002	0.998	0.000
C92.1 Chronic myeloid leukaemia	0.002	0.998	0.000
E53.9 Vitamin B deficiency, unspecified	0.002	0.998	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
Chapter IV Endocrine, nutritional and metabolic diseases	0.002	0.998	0.000
M21.16 Varus deformity, not elsewhere classified (Lower leg)	0.002	0.998	0.000
C95.9 Leukaemia, unspecified	0.002	0.998	0.000
C95.7 Other leukaemia of unspecified cell type	0.002	0.998	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.002	0.998	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.002	0.998	0.000
K11.5 Sialolithiasis	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
C82.1 Mixed small cleaved and large cell, follicular	0.002	0.998	0.000
N64.8 Other specified disorders of breast	0.002	0.998	0.000
C93.9 Monocytic leukaemia, unspecified	0.002	0.998	0.000
C93.7 Other monocytic leukaemia	0.002	0.998	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.002	0.998	0.000
C93.2 Subacute monocytic leukaemia	0.002	0.998	0.000
C93.0 Acute monocytic leukaemia	0.002	0.998	0.000
E28.3 Primary ovarian failure	0.002	0.998	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.002	0.998	0.000
C85.0 Lymphosarcoma	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.002	0.998	0.000
E53.8 Deficiency of other specified B group vitamins	0.002	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.998	0.002
C88.9 Malignant immunoproliferative disease, unspecified	0.002	0.998	0.000
C88.7 Other malignant immunoproliferative diseases	0.002	0.998	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.002	0.998	0.000
C88.3 Immunoproliferative small intestinal disease	0.002	0.998	0.000
C88.2 Gamma heavy chain disease	0.002	0.998	0.000
C88.1 Alpha heavy chain disease	0.002	0.998	0.000
E13.9 Without complications	0.002	0.998	0.000
F45.9 Somatoform disorder, unspecified	0.002	0.998	0.000
F45.4 Persistent somatoform pain disorder	0.002	0.998	0.000
F45.3 Somatoform autonomic dysfunction	0.002	0.998	0.000
F45.2 Hypochondriacal disorder	0.002	0.998	0.000
F45.1 Undifferentiated somatoform disorder	0.002	0.998	0.000
F45.0 Somatisation disorder	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
F48 Other neurotic disorders	0.002	0.998	0.000
M11.29 Other chondrocalcinosis (Site unspecified)	0.000	0.998	0.002
M11.28 Other chondrocalcinosis (Other)	0.000	0.998	0.002
M11.27 Other chondrocalcinosis (Ankle and foot)	0.000	0.998	0.002
M11.25 Other chondrocalcinosis (Pelvic region and thigh)	0.000	0.998	0.002
M11.24 Other chondrocalcinosis (Hand)	0.000	0.998	0.002
M11.23 Other chondrocalcinosis (Forearm)	0.000	0.998	0.002
M11.22 Other chondrocalcinosis (Upper arm)	0.000	0.998	0.002
M11.21 Other chondrocalcinosis (Shoulder region)	0.000	0.998	0.002
M11.20 Other chondrocalcinosis (Multiple sites)	0.000	0.998	0.002
C83.0 Small cell (diffuse)	0.002	0.998	0.000
D73.0 Hyposplenism	0.000	0.998	0.002
S61.9 Open wound of wrist and hand, part unspecified	0.002	0.998	0.000
H43.2 Crystalline deposits in vitreous body	0.002	0.998	0.000
U80.1 Methicillin resistant agent	0.002	0.998	0.000
G12 Spinal muscular atrophy and related syndromes	0.002	0.998	0.000
K50.0 Crohn's disease of small intestine	0.000	0.998	0.002
N89.8 Other specified noninflammatory disorders of vagina	0.000	0.998	0.002
T50.8 Diagnostic agents	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
T50.5 Appetite depressants	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.002
H43 Disorders of vitreous body	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
E27 Other disorders of adrenal gland	0.002	0.998	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.001	0.998	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.001	0.998	0.000
C86.4 Blastic NK-cell lymphoma	0.001	0.998	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.001	0.998	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.001	0.998	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.001	0.998	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.001	0.998	0.000
C90.3 Solitary plasmacytoma	0.002	0.998	0.000
C90.1 Plasma cell leukaemia	0.002	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.002	0.998	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.002	0.998	0.000
C92.7 Other myeloid leukaemia	0.002	0.998	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.002	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.002	0.998	0.000
C92.4 Acute promyelocytic leukaemia	0.002	0.998	0.000
C92.3 Myeloid sarcoma	0.002	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.002	0.998	0.000
C94.7 Other specified leukaemias	0.001	0.998	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.001	0.998	0.000
C94.5 Acute myelofibrosis	0.001	0.998	0.000
C94.4 Acute panmyelosis	0.001	0.998	0.000
C94.3 Mast cell leukaemia	0.001	0.998	0.000
C94.2 Acute megakaryoblastic leukaemia	0.001	0.998	0.000
C94.1 Chronic erythraemia	0.001	0.998	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.001	0.998	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.001	0.998	0.000
C96.8 Histiocytic sarcoma	0.001	0.998	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.001	0.998	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.001	0.998	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.001	0.998	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.001	0.998	0.000
C96.3 True histiocytic lymphoma	0.001	0.998	0.000
C96.2 Malignant mast cell tumour	0.001	0.998	0.000
C96.1 Malignant histiocytosis	0.001	0.998	0.000
C96.0 Letterer-Siwe disease	0.001	0.998	0.000
M95 Other acquired deformities of musculoskeletal system and connective tissue	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
M21.06 Valgus deformity, not elsewhere classified (Lower leg)	0.002	0.998	0.000
M54.19 Radiculopathy (Site unspecified)	0.000	0.998	0.001
M54.12 Radiculopathy (Cervical region)	0.000	0.998	0.002
M54.23 Cervicalgia (Cervicothoracic region)	0.000	0.998	0.001
F44 Dissociative [conversion] disorders	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.001	0.998	0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.001	0.998	0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.001	0.998	0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.001	0.998	0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.001	0.998	0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.001	0.998	0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.001	0.998	0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.001	0.998	0.000
F43.9 Reaction to severe stress, unspecified	0.001	0.998	0.000
G63.8 Polyneuropathy in other diseases classified elsewhere	0.002	0.998	0.000
G63.6 Polyneuropathy in other musculoskeletal disorders	0.002	0.998	0.000
G63.5 Polyneuropathy in systemic connective tissue disorders	0.002	0.998	0.000
G63.4 Polyneuropathy in nutritional deficiency	0.002	0.998	0.000
G63.3 Polyneuropathy in other endocrine and metabolic diseases	0.002	0.998	0.000
G63.1 Polyneuropathy in neoplastic disease	0.002	0.998	0.000
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.998	0.002
S62.50 Fracture of thumb (closed)	0.002	0.998	0.000
F41.9 Anxiety disorder, unspecified	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations